Weld Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-5,108
| Closed | -$442K | – | 580 |
|
|
2020
Q1 | $442K | Buy |
+5,108
| New | +$442K | 0.23% | 160 |
|
|
2019
Q4 | – | Sell |
-4,733
| Closed | -$426K | – | 819 |
|
|
2019
Q3 | $426K | Buy |
+4,733
| New | +$426K | 0.08% | 441 |
|
|
2019
Q2 | – | Sell |
-7,204
| Closed | -$635K | – | 875 |
|
|
2019
Q1 | $635K | Sell |
7,204
-1,362
| -16% | -$120K | 0.12% | 324 |
|
|
2018
Q4 | $612K | Buy |
+8,566
| New | +$612K | 0.14% | 284 |
|